Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 3.75% is 129% above its 5-year average of -12.83%, near the high end of its 5-year range (-177.87%–38.35%).
331.84% above its 12-month average of -1.62%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 6.52%.
EBITDA MARGIN
3.75%
EBITDA MARGIN AVG TTM
-1.62%
EBITDA MARGIN AVG 3Y
-9.52%
EBITDA MARGIN AVG 5Y
-12.83%
EBITDA MARGIN AVG 10Y
-6.34%
EBITDA MARGIN AVG 15Y
-19.14%
EBITDA MARGIN AVG 20Y
-30.15%
CURRENT VS TTM AVG
+331.84%
CURRENT VS 3Y AVG
+139.38%
CURRENT VS 5Y AVG
+129.22%
CURRENT VS 10Y AVG
+159.14%
CURRENT VS 15Y AVG
+119.59%
CURRENT VS 20Y AVG
+112.44%
BioLife Solutions, Inc.
Market Cap
$1.89B
EBITDA Margin
3.75%
TTM Avg
-1.62%
3Y Avg
-9.52%
5Y Avg
-12.83%
Market Cap
$1.90B
EBITDA Margin
-864.28%
TTM Avg
-1007.63%
3Y Avg
-1530.50%
5Y Avg
-1530.50%
Market Cap
$1.91B
EBITDA Margin
-13.52%
TTM Avg
-19.53%
3Y Avg
-24.36%
5Y Avg
-23.78%
Market Cap
$1.86B
EBITDA Margin
-157.11%
TTM Avg
-157.28%
3Y Avg
-157.28%
5Y Avg
-157.28%
Market Cap
$1.92B
EBITDA Margin
-3042.18%
TTM Avg
-3200.65%
3Y Avg
-2392.49%
5Y Avg
-2392.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 3.75% | -1.62% | -9.52% | -12.83% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -864.28% | -1007.63% | -1530.50% | -1530.50% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.91B | -13.52% | -19.53% | -24.36% | -23.78% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | -157.11% | -157.28% | -157.28% | -157.28% |
| Immunome, Inc. (IMNM)vs › | $1.92B | -3042.18% | -3200.65% | -2392.49% | -2392.49% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 3.91% | 4.83% | 6.92% | 8.21% |
| Novavax, Inc. (NVAX)vs › | $1.83B | 52.59% | 11.61% | -27.43% | -466.07% |
| Azenta, Inc. (AZTA)vs › | $1.84B | 8.41% | 9.50% | 6.21% | 7.73% |
| AxoGen, Inc. (AXGN)vs › | $1.95B | 0.15% | 1.29% | -6.34% | -9.86% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 31.38% | 29.77% | 26.47% | 27.37% |
Gross Margin
64.5%
EBITDA Margin
3.8%
Operating Margin
-1.1%
Net Margin
49.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 6.52% |
| 2026-03-31 | 2.64% |
| 2025-12-31 | 38.35% |
| 2025-09-30 | 4.44% |
| 2025-06-30 | -60.03% |
| 2025-03-31 | 0.69% |
| 2024-12-31 | -90.25% |
| 2024-09-30 | 2.48% |
| 2024-06-30 | 5.36% |
| 2024-03-31 | -5.52% |
| 2023-12-31 | -32.91% |
| 2023-09-30 | -51.75% |
| 2023-06-30 | -24.53% |
| 2023-03-31 | -27.65% |
| 2022-12-31 | -106.33% |
| 2022-09-30 | -18.23% |
| 2022-06-30 | -177.87% |
| 2022-03-31 | -9.53% |
| 2021-12-31 | -34.19% |
| 2021-09-30 | -22.17% |
| 2021-06-30 | -4.98% |
| 2021-03-31 | 4.33% |
| 2020-12-31 | -21.93% |
| 2020-09-30 | -4.79% |
| 2020-06-30 | 7.56% |
| 2020-03-31 | 8.70% |
| 2019-12-31 | 4.56% |
| 2019-09-30 | -3.74% |
| 2019-06-30 | 14.36% |
| 2019-03-31 | 11.51% |
| 2018-12-31 | 20.82% |
| 2018-09-30 | 24.16% |
| 2018-06-30 | 26.42% |
| 2018-03-31 | 5.70% |
| 2017-12-31 | -4.44% |
| 2017-09-30 | 1.73% |
| 2017-06-30 | -9.95% |
| 2017-03-31 | -15.83% |
| 2016-12-31 | -23.79% |
| 2016-09-30 | -48.96% |
| 2016-06-30 | -75.47% |
| 2016-03-31 | -75.63% |
| 2015-12-31 | -72.36% |
| 2015-09-30 | -74.12% |
| 2015-06-30 | -71.54% |
| 2015-03-31 | -71.76% |
| 2015-01-31 | -55.81% |
| 2014-09-30 | -65.24% |
| 2014-06-30 | -68.29% |
| 2014-03-31 | -14.84% |
| 2013-12-31 | -9.65% |
| 2013-09-30 | -2.08% |
| 2013-06-30 | -1.00% |
| 2013-03-31 | 11.62% |
| 2012-12-31 | -12.11% |
| 2012-09-30 | -5.83% |
| 2012-06-30 | -24.94% |
| 2012-03-31 | -18.28% |
| 2011-12-31 | -22.76% |
| 2011-09-30 | -36.37% |
| 2011-06-30 | -38.00% |
| 2011-03-31 | -70.63% |
| 2010-12-31 | -52.18% |
| 2010-09-30 | -50.36% |
| 2010-06-30 | -78.77% |
| 2010-03-31 | -75.87% |
| 2009-12-31 | -87.35% |
| 2009-09-30 | -90.79% |
| 2009-06-30 | -232.85% |
| 2009-03-31 | -191.94% |
| 2008-09-30 | 799171.46% |
| 2008-06-30 | -211.53% |
| 2008-03-31 | -160.56% |
| 2007-12-31 | 45970.05% |
| 2007-09-30 | -185752121.40% |
| 2007-06-30 | 220797279.73% |
| 2007-03-31 | 216571728.39% |
| 2006-12-31 | -247.73% |
| 2006-09-30 | -308.57% |
| 2006-06-30 | -276.37% |
| 2006-03-31 | -220.78% |
| 2005-12-31 | -77.92% |
| 2005-09-30 | -87.83% |
| 2005-06-30 | -85.55% |
| 2005-03-31 | -124.96% |
| 2004-12-31 | 10.92% |
| 2004-09-30 | -88.51% |
| 2004-06-30 | -151.59% |
| 2004-03-31 | -92.03% |
| 2003-12-31 | -95.64% |
| 2003-09-30 | -290.35% |
| 2003-03-31 | 23.82% |
| 2002-12-31 | -59.87% |
| 2002-09-30 | -77.24% |
